跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
怡万之 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Ertapenem Sodium for Injection
Approved
化学药品
Ertapenem Sodium for Injection
Merck Sharp & Dohme BV
🇨🇳 National Medical Products Administration
Approval Date
Nov 29, 2024
Approval ID
8fOMxde4oF3
Company
Merck Sharp & Dohme BV
Type
化学药品
Approval Details
Approval Id
8fOMxde4oF3
Approval Number
国药准字HJ20150480
Generic Name
注射用厄他培南钠
Generic Name En
Ertapenem Sodium for Injection
Trade Name
怡万之
Drug Type
化学药品
Dosage Form
注射剂
Strength
1g(以C₂₂H₂₅N₃O₇S计)
Reg Date
2024-11-29
Expired Date
2029-11-28
Company Name
Merck Sharp & Dohme BV
Production Company Name
FAREVA MIRABEL
Company Detail Path
/organization/merck-sharp-and-dohme-bv
Production Company Detail Path
/organization/fareva-mirabel
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 29, 2024
Approval ID
8fOMxde4oF3
Type
化学药品
Back to NMPA Approvals